Who is sponsoring NCT05595421?

NCT05595421 is sponsored by Tri-Service General Hospital.

What drugs are being tested in NCT05595421?

Interventions in NCT05595421: Transcranial direct current stimulation (tDCS).

What condition does NCT05595421 study?

NCT05595421 studies Obsessive-Compulsive Disorder.

Is NCT05595421 still recruiting?

NCT05595421 is currently completed. Last updated 28 November 2023.

Last reviewed 2023-11-28 · How we verify

NCT05595421

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical and Electrophysiological Outcomes of tDCS in Patients With Treatment Resistant OCD

Completed NA Last updated 28 November 2023

What this trial tests

NA trial testing Transcranial direct current stimulation (tDCS) in Obsessive-Compulsive Disorder in 18 participants. Completed in 31 May 2023.

Timeline

10 July 2019

Primary endpoint
31 May 2023

31 May 2023

Quick facts

Lead sponsor	Tri-Service General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	18
Start date	10 July 2019
Primary completion	31 May 2023
Estimated completion	31 May 2023
Sites	1 location across Taiwan

Drugs / interventions tested

Transcranial direct current stimulation (tDCS)

Conditions studied

Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →

Sponsor

Tri-Service General Hospital

Who can join

Adults 20 to 65, any sex, with Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to analyze the effectiveness of three different montages of transcranial direct current stimulation (tDCS) in treating treatment-resistant OCD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparing Different Montages of Transcranial Direct Current Stimulation in Treating Treatment-Resistant Obsessive Compulsive Disorder: A Randomized, Single-Blind Clinical Trial.
Chu CS, Lin YY, Huang CC, Chung YA, et al · · 2025 · PMID 40005287 · DOI 10.3390/medicina61020169

Verify or expand the search:

Other trials of Transcranial direct current stimulation (tDCS)

Trials testing the same drug.

NCT07414537 — Remotely Administered tDCS to Improve Cognitive Function in Veterans With mTBI and PTSD Principal Investigator · Phase 2 · not yet recruiting
NCT06959342 — Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treat · NA · recruiting
NCT06838013 — Effect of Combining Central and Peripheral Cutaneous Electrical Stimulation on Lower Limb Motor Function in People With · NA · recruiting
NCT06240377 — Effectiveness of NMP and TDCS vs Pharmacological Treatment in Cancer Patients With Lower Limb Pain · NA · withdrawn
NCT05962281 — Investigation The Effect of Conventional Vs. Individualized tDCS Intensity to Achieve Uniform E-Fields · NA · unknown

Other recruiting trials for Obsessive-Compulsive Disorder

Currently open trials in the same condition.

NCT06575075 — Pilot Study of RR-HNK in OCD · Phase 1, PHASE2 · recruiting
NCT05783817 — MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) · Phase 2 · recruiting
NCT07065669 — Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation · NA · recruiting
NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
NCT07000812 — EEG Evaluation of CBT for Obsessive-Compulsive Disorder · NA · active not recruiting

Other Tri-Service General Hospital trials

Trials by the same sponsor.

NCT07515495 — Effectiveness of Intensive Tutoring vs. Flexible Self-Learning on Digital Health Literacy and Self-Efficacy for "My Heal · NA · recruiting
NCT07589322 — Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs · NA · recruiting
NCT07327385 — To Investigate the Change of Brain and Autonomic Function From Different Protocols of Repeated Transcranial Magnetic Sti · NA · not yet recruiting
NCT07355023 — AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Targe · NA · recruiting
NCT07241182 — Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05595421 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tri-Service General Hospital
Last refreshed: 28 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05595421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing